Contraction band necrosis in two ecstasy abusers: A latent lethal lesion associated with ecstasy

American Journal of Forensic Medicine and Pathology

Volumn 30, Issue 3, 2009, Pages 295-297

  Hua, Yi Shao ^a   Liang, Ren ^a   Liang, Liu ^a   Huang, Guang Zhao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Contraction band necrosis; Ecstasy; Histopathology; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CELL INFILTRATION; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CYANOSIS; DRUG ABUSE; DRUG USE; HEART ARREST; HEART MUSCLE; HEART MUSCLE NECROSIS; HEART VENTRICLE SEPTUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPYREXIA; HYPERSALIVATION; HYPOTENSION; INTOXICATION; LETHALITY; LIP; LYMPHOCYTIC INFILTRATION; MALE; MEDICAL EXAMINATION; MEDICOLEGAL ASPECT; MONOCYTE; MYOCARDIAL CONTRACTION BAND NECROSIS; RESTLESSNESS; TABLET; TOXICOLOGY; TRISMUS;

ADULT; AMPHETAMINE-RELATED DISORDERS; EOSINOPHILS; FORENSIC PATHOLOGY; HALLUCINOGENS; HEPATOCYTES; HUMANS; LYMPHOCYTES; MALE; MONOCYTES; MYOCARDIAL CONTRACTION; MYOCARDIUM; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NECROSIS; PAPILLARY MUSCLES; PULMONARY EDEMA;

EID: 69549114497     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAF.0b013e318187e756     Document Type: Article

References (22)

1. Henry JA, Jeffreys KJ, Dawling S, et al. Toxicity and deaths from 3, 4-methylenedioxymethamphetamine ("Ecstasy"). Lancet. 1992;340:384-387.
2. Milroy CM, Clark JC, Forrest AR. Pathology of deaths associated with "Ecstasy" and "Eve" misuse. J Clin Pathol. 1996;49:149-153.
3. Lester SJ, Baggott M, Welm S, et al. Cardiovascular effects of 3, 4-methylenedioxymethamphetamine: a double-blind placebo-controlled trial. Ann Intern Med. 2000;133:969-973. (Pubitemid 32003513)
4. Mas M, Farré M, de la Torre R, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4- methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther. 1999;290:136-145. (Pubitemid 29302313)
5. Jacobs W. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications. Am J Forensic Med Pathol. 2006;27:156-160. (Pubitemid 44357112)
6. Patel MM, Belson MG, Wright D, et al. Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study. Resuscitation. 2005;66:197-202. (Pubitemid 41033390)
7. Karch S. Karch's Pathology of Drug Abuse. Boca Raton, FL: CRC Press; 2002:288-294.
8. Garcia-Repetto R, Moreno E, Soriano T, et al. Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose. Forensic Sci Int. 2003;135:110-114. (Pubitemid 36960216)
9. Burgess C, O'Donohoe A, Gill M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry. 2000;15:287-294. (Pubitemid 30643932)
10. Gill JR, Hayes JA, deSouza IS, et al. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forensic Sci. 2002;47:121-126.
11. Qasim A, Townend J, Davies MK. Ecstasy induced acute myocardial infarction. Heart. 2001;85:E10.
12. Baroldi G, Mittleman RE, Parolini M, et al. Myocardial contraction bands, definition: quantification and significance in forensic pathology. Int J Legal Med. 2001;115:142-151. (Pubitemid 33123762)
13. Baroldi G. Different types of myocardial necrosis in coronary heart disease: a pathophysiologic review of their functional significance. Am Heart J. 1975;89:742-752.
14. Todd GL, Baroldi G, Pieper GM, et al. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification, and regional distribution of acute contraction band lesions. J Mol Cell Cardiol. 1985;17:317-318. (Pubitemid 15030722)
15. Todd GL, Baroldi G, Pieper GM, et al. Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic, and biochemical changes. J Mol Cell Cardiol. 1985;17:647-656. (Pubitemid 15065024)
16. Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1979;217:703-709.
17. Baroldi G, Silver MD, Lixfield W, et al. Irreversible myocardial damage resembling catecholamine necrosis secondary to acute coronary occlusion in dogs: its prevention by propranolol. J Mol Cell Cardiol. 1977;9:687-691. (Pubitemid 8162634)
18. Lameris TW, Zeeuw de S, Albert G, et al. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation. 2000;101:2645-2650.
19. Fineschi V, Baroldi G, Centini F, et al. Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int J Legal Med. 2001;114:323-330. (Pubitemid 32691854)
20. Leadbeatter S, Wawman HM, Jasani B. Immunocytochemical diagnosis of early myocardial ischemic/hypoxic damage. Forensic Sci Int. 1989;40:171-180. (Pubitemid 19091100)
21. Wijetunga M, Seto T, Lindsay J. Crystal methamphetamine associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 2003;41:981-986. (Pubitemid 38018490)
22. Fineschi V, Wetli CW, Di Paolo M, et al. Myocardial necrosis and cocaine: a quantitative morphologic study in 26 cocaine-associated deaths. Int J Legal Med. 1997;110:193-198. (Pubitemid 27323773)